HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Miossec Selected Research

P Miossec Research Topics

Disease

28Rheumatoid Arthritis
10/2011 - 05/2000
11Inflammation (Inflammations)
01/2021 - 06/2000
7Necrosis
01/2018 - 11/2001
5Myositis (Idiopathic Inflammatory Myopathies)
07/2010 - 02/2003
5Arthritis (Polyarthritis)
08/2005 - 06/2000
3Dermatomyositis (Dermatopolymyositis)
07/2010 - 09/2000
3Bone Resorption
06/2001 - 01/2001
2Polymyositis
07/2010 - 04/2003
2Synovitis
07/2009 - 07/2008
2Joint Diseases (Joint Disease)
07/2008 - 06/2004
2Infections
08/2005 - 09/2000
2Arthralgia (Joint Pain)
08/2005 - 10/2004
1Cytokine Release Syndrome
01/2021
1COVID-19
01/2021
1Myocardial Infarction
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2019
1Fibrosis (Cirrhosis)
10/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Osteoarthritis
10/2009
1Neutropenia
06/2008
1Periodontal Diseases (Periodontal Disease)
07/2006
1Hepatitis C
08/2005
1Tuberculosis (Tuberculoses)
03/2005
1Exanthema (Rash)
01/2005
1Pain (Aches)
10/2004
1Knee Osteoarthritis
06/2004
1Myalgia
11/2001
1Meningitis
11/2001
1Aseptic Meningitis
11/2001
1Ankylosing Spondylitis
10/2001
1Chronic Kidney Failure (Chronic Renal Failure)
07/2001
1Experimental Arthritis
06/2000

Drug/Important Bio-Agent (IBA)

11CytokinesIBA
01/2021 - 05/2000
8Interleukin-17 (Interleukin 17)IBA
10/2019 - 06/2000
6Infliximab (Remicade)FDA Link
08/2009 - 11/2001
5Interleukin-1 (Interleukin 1)IBA
01/2021 - 06/2001
5Biomarkers (Surrogate Marker)IBA
10/2011 - 03/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2005 - 06/2001
4InterleukinsIBA
01/2020 - 09/2005
4EpitopesIBA
09/2006 - 10/2001
3Interleukin-6 (Interleukin 6)IBA
01/2018 - 08/2002
3Proteins (Proteins, Gene)FDA Link
10/2009 - 08/2002
3Biological ProductsIBA
08/2009 - 08/2005
3ChemokinesIBA
03/2009 - 11/2001
3Interleukin-4 (Interleukin 4)IBA
03/2005 - 06/2000
3Pharmaceutical PreparationsIBA
01/2005 - 11/2001
2Collagen Type III (Type III Collagen)IBA
10/2009 - 03/2009
2HLA-DR Antigens (HLA-DR)IBA
07/2006 - 10/2001
2Methotrexate (Mexate)FDA LinkGeneric
08/2005 - 10/2004
2CollagenIBA
06/2004 - 08/2002
2DNA (Deoxyribonucleic Acid)IBA
02/2003 - 09/2000
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2002 - 06/2001
2Collagen Type I (Type I Collagen)IBA
08/2002 - 06/2000
1Toll-Like Receptor 7IBA
07/2010
1Toll-Like Receptor 3IBA
07/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2009
1Tyrosine (L-Tyrosine)FDA Link
10/2009
1Nucleic AcidsIBA
09/2009
1Platelet Factor 4IBA
08/2009
1Apolipoprotein A-I (Apolipoprotein A1)IBA
08/2009
1collagen type I trimeric cross-linked peptideIBA
03/2009
1IronIBA
07/2008
1Rituximab (Mabthera)FDA Link
06/2008
1Transaminases (Aminotransferases)IBA
01/2007
1Etanercept (Enbrel)FDA Link
01/2007
1HLA-DRB1 Chains (HLA DRB1)IBA
09/2006
1NF-kappa B (NF-kB)IBA
09/2005
1Rheumatoid FactorIBA
08/2005
1InterferonsIBA
08/2005
1Antinuclear AntibodiesIBA
08/2005
1Complement System Proteins (Complement)IBA
08/2005
1CryoglobulinsIBA
08/2005
1Interferon-gamma (Interferon, gamma)IBA
03/2005
1Transcription Factors (Transcription Factor)IBA
03/2005
1Interleukin-12 (IL 12)IBA
03/2005
1Leflunomide (Arava)FDA LinkGeneric
01/2005
1ProcollagenIBA
06/2004
1Interleukin-1beta (Interleukin 1 beta)IBA
04/2003
1factor AIBA
11/2001
1AntibodiesIBA
11/2001
1HLA-B27 Antigen (HLA B27 Antigen)IBA
10/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2001
1Chemokine ReceptorsIBA
07/2001
1AA amyloidosisIBA
07/2001
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2001
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
10/2000
1GTP-Binding Proteins (G-Protein)IBA
09/2000
1RANK LigandIBA
06/2000
1Tartrate-Resistant Acid PhosphataseIBA
06/2000

Therapy/Procedure

4Therapeutics
01/2020 - 06/2001
1Occupational Therapy (Therapy, Occupational)
03/2009
1Intramuscular Injections
10/2004
1Oral Administration
10/2004